- Home
- AACO vs CATX Comparison
AACO vs CATX Comparison
Compare AACO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$3.30
Company Overview
Basic Information| Metric | AACO | CATX |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.4M | 341.0M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AACO | CATX |
|---|---|---|
| Price | $9.98 | $3.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 11.5K | ★ 1.1M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.89 | $1.96 |
| 52 Week High | $9.99 | $6.16 |
Technical Indicators
Market Signals| Indicator | AACO | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 71.72 | 57.25 |
| Support Level | $9.92 | $2.82 |
| Resistance Level | $9.99 | $3.78 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 85.71 | 65.62 |
Price Performance
Historical Comparison AACO
CATX
About AACO Abony Acquisition Corp. I Class A Ordinary Share
Abony Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.